Antileukemic potential of Momordica charantia seed extracts on human myeloid leukemic HL60 cells

Evidence-based Complementary and Alternative Medicine

Volumn 2012, Issue , 2012, Pages

  Soundararajan, Ramani ^a,b   Prabha, Punit ^a   Rai, Umesh ^b   Dixit, Aparna ^a  

^a JAWAHARLAL NEHRU UNIVERSITY   (India)

^b UNIVERSITY OF DELHI   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ACETONE; ALCOHOL; CD11B ANTIGEN; ESTERASE; MOMORDICA CHARANTIA EXTRACT;

ANTIGEN EXPRESSION; ARTICLE; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; CELL STRAIN HL 60; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; GRANULOCYTE; HUMAN; HUMAN CELL; MOMORDICA CHARANTIA; ONCOGENE C MYC; PLANT SEED; PRIORITY JOURNAL; SOLVENT EXTRACTION; TIME;

EID: 84862272713     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2012/732404     Document Type: Article

References (51)

1. Abdel-Wahab O., Levine R. L., Recent advances in the treatment of acute myeloid leukemia F1000 Medicine Reports 2010 2 1 55
2. Chopra A., Doiphode V. V., Ayurvedic medicine: core concept, therapeutic principles, and current relevance Medical Clinics of North America 2002 86 1 75 89 (Pubitemid 34027999)
3. Aggarwal B. B., Bhardwaj A., Aggarwal R. S., Seeram N. P., Shishodia S., Takada Y., Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies Anticancer Research A 2004 24 5 2783 2840 (Pubitemid 39409568)
4. Aggarwal B. B., Kumar A., Bharti A. C., Anticancer potential of curcumin: preclinical and clinical studies Anticancer Research A 2003 23 1 363 398 (Pubitemid 36361976)
5. Venugopal P. M., Prince S. M., Sounyanath A., Traditional medicines for modern times Antidiabetic Plants 2006 New York, NY, USA CRC Press
6. Behera T. K., Behera S., Bharathi L. K., John J. K., Simon P. W., Staub J. E., Janick J., Bitter gourd: botany, horticulture and breeding Horticultural Reviews 2010 37 Koln, Germany Wiley-VCH 101 141
7. Ng T. B., Liu W. K., Sze S. F., Yeung H. W., Action of -momorcharin, a ribosome inactivating protein, on cultured tumor cell lines General Pharmacology 1994 25 1 75 77
8. Lee-Huang S., Huang P. L., Chen H. C., Huang P. L., Bourinbaiar A., Huang H. I., Kung H. F., Anti-HIV and anti-tumor activities of recombinant MAP30 from bitter melon Gene 1995 161 2 151 156
9. Shi H., Hiramatsu M., Komatsu M., Kayama T., Antioxidant property of Fructus Momordicae extract Biochemistry and Molecular Biology International 1996 40 6 1111 1121 (Pubitemid 27032389)
10. Grover J. K., Yadav S. P., Pharmacological actions and potential uses of Momordica charantia: a review Journal of Ethnopharmacology 2004 93 1 123 132 (Pubitemid 38739282)
11. West M. E., Sidrak G. H., Street S. P., The anti-growth properties of extracts from Momordica charantia L West Indian Medical Journal 1971 20 1 25 34
12. Akihisa T., Higo N., Tokuda H., Ukiya M., Akazawa H., Tochigi Y., Kimura Y., Suzuki T., Nishino H., Cucurbitane-type triterpenoids from the fruits of Momordica charantia and their cancer chemopreventive effects Journal of Natural Products 2007 70 8 1233 1239 (Pubitemid 47401558)
13. Vesely D. L., Graves W. R., Lo T. M., Isolation of a guanylate cyclase inhibitor from the balsam pear (Momordica charantia abreviata) Biochemical and Biophysical Research Communications 1977 77 4 1294 1299 (Pubitemid 8270692)
14. Claflin A. J., Vesely D. L., Hudson J. L., Inhibition of growth and guanylate cyclase activity of an undifferentiated prostate adenocarcinoma by an extract of the balsam pear (Momordica charantia abbreviata) Proceedings of the National Academy of Sciences of the United States of America 1978 75 2 989 993 (Pubitemid 8298498)
15. Barbieri L., Lorenzoni E., Stirpe F., Inhibition of protein synthesis in vitro by a lectin from Momordica charantia and by other haemagglutinins Biochemical Journal 1979 182 2 633 635 (Pubitemid 10226481)
16. Takemoto D. J., Dunford C., McMurray M. M., The cytotoxic and cytostatic effects of the bitter melon (Momordica charantia) on human lymphocytes Toxicon 1982 20 3 593 599 (Pubitemid 12008972)
17. Jilka C., Strifler B., Fortner G. W., In vivo antitumor activity of the bitter melon (Momordica charantia) Cancer Research 1983 43 11 5151 5155 (Pubitemid 14227492)
18. Collins S. J., Bodner A., Ting R., Gallo R. C., Induction of morphological and functional differentiation of human promyelocytic leukemia cells (HL-60) by compounds which induce differentiation of murine leukemia cells International Journal of Cancer 1980 25 2 213 218 (Pubitemid 10217394)
19. Shuto T., Furuta T., Cheung J., Gruenert D. C., Ohira Y., Shimasaki S., Suico M. A., Sato K., Kai H., Increased responsiveness to TLR2 and TLR4 ligands during dimethylsulfoxide-induced neutrophil-like differentiation of HL-60 myeloid leukemia cells Leukemia Research 2007 31 12 1721 1728 (Pubitemid 350051411)
20. Lee K. W., Kim H. J., Lee Y. S., Park H. J., Choi J. W., Ha J., Lee K. T., Acteoside inhibits human promyelocytic HL-60 leukemia cell proliferation via inducing cell cycle arrest at G0/G1 phase and differentiation into monocyte Carcinogenesis 2007 28 9 1928 1936 (Pubitemid 47500605)
21. Montenegro R. C., de Vasconcellos M. C., Silva Bezerra F., Andrade-Neto M., Pessoa C., de Moraes M. O., Costa-Lotufo L. V., Pisosterol induces monocytic differentiation in HL-60 cells Toxicology in Vitro 2007 21 5 795 800 (Pubitemid 46603233)
22. Sirohi P. S., Improvement in cucurbit vegetable Indian Horticulture 1997 42 64 67
23. Lowry O. H., Rosenbrough N. J., Farr A. L., Randall R. J., Protein measurement with the Folin phenol reagent The Journal of biological chemistry 1951 193 1 265 275
24. Yedjou C. G., Moore P., Tchounwou P. B., Dose- and time-dependent response of human leukemia (HL-60) cells to arsenic trioxide treatment International Journal of Environmental Research and Public Health 2006 3 2 136 140 (Pubitemid 350002697)
25. Breitman T. R., Selonick S. E., Collins S. J., Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid Proceedings of the National Academy of Sciences of the United States of America 1980 77 5 2936 2940 (Pubitemid 10049852)
26. Ohri S., Sharma D., Dixit A., Modulation of c-myc and c-fos gene expression in regenerating rat liver by 2-mercaptopropionylglycine Cell Biology International 2002 26 2 187 192
27. Alone P. V., Malik G., Krishnan A., Garg L. C., Deletion mutations in N-terminal 1 helix render heat labile entertotoxin subunit susceptible to degradation Proceedings of the National Academy of Sciences of the United States of America 2007 104 16058 16061
28. Douer D., Koeffler H. P., Retinoic acid. Inhibition of the clonal growth of human myeloid leukemia cells Journal of Clinical Investigation 1982 69 2 277 283 (Pubitemid 12177605)
29. Asou H., Koike M., Elstner E., Cambell M., Le J., Uskokovic M. R., Kamada N., Koeffler H. P., 19-nor vitamin-D analogs: a new class of potent inhibitors of proliferation and inducers of differentiation of human myeloid leukemia cell lines Blood 1998 92 7 2441 2449 (Pubitemid 28452987)
30. Molnr I., Kute T., Willingham M. C., Powell B. L., Dodge W. H., Schwartz G. G., 19-Nor-1, 25-dihydroxyvitamin D2 (paricalcitol): effects on clonal proliferation, differentiation, and apoptosis in human leukemic cell lines Journal of Cancer Research and Clinical Oncology 2003 129 1 35 42 (Pubitemid 36403258)
31. Kharbanda S. M., Sherman M. L., Spriggs D. R., Kufe D. W., Effects of tiazofurin on protooncogene expression during HL-60 cell differentiation Cancer Research 1988 48 21 5965 5968 (Pubitemid 18266784)
32. Watanabe T., Sariban E., Mitchell T., Kufe D., Human c-myc and N-ras expression during induction of HL-60 cellular differentiation Biochemical and Biophysical Research Communications 1985 126 3 999 1005 (Pubitemid 15148963)
33. Lachman H. M., Skoultchi A. I., Expression of c-myc changes during differentiation of mouse erythroleukaemia cells Nature 1984 310 5978 592 594 (Pubitemid 14053904)
34. Sharma V., Gupta D. K., Sharma J. P., Selective anti-proliferative effect of ocimum, ginger and bitter gourd on human cancer cells IJPI's Journal of Biotechnology and Biotherapeutics 2011 2 12 16
35. Jing Y., Nakajo S., Xia L., Nakaya K., Fang Q., Waxman S., Han R., Boswellic acid acetate induces differentiation and apoptosis in leukemia cell lines Leukemia Research 1999 23 1 43 50 (Pubitemid 28484867)
36. Kawaii S., Tomono Y., Katase E., Ogawa K., Yano M., Takemura Y., Ju-ichi M., Ito C., Furukawa H., Acridones as inducers of HL-60 cell differentiation Leukemia Research 1999 23 3 263 269 (Pubitemid 29083383)
37. Boyd A. W., Metcalf D., Induction of differentiation in HL60 leukaemic cells: a cell cycle dependent all-or-none event Leukemia Research 1984 8 1 27 43 (Pubitemid 14155212)
38. Tanaka H., Abe E., Miyaura C., 1,25-Dihydroxycholecalciferol and a human myeloid leukaemia cell line (HL-60). The presence of a cytosol receptor and induction of differentiation Biochemical Journal 1982 204 3 713 719 (Pubitemid 12009149)
39. Radhika S., Choudhary S. K., Garg L. C., Dixit A., Induction of differentiation in murine erythroleukemia cells by 1,25-dihydroxy vitamin D3 Cancer Letters 1995 90 2 225 230
40. Choudhary S. K., Sharma D., Dixit A., D,L- -difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase, induces differentiation in MEL cells Cell Biology International 1999 23 7 489 495 (Pubitemid 30125204)
41. Levenson R., Housman D., Memory of MEL cells to a previous exposure to inducer Cell 1979 17 3 485 490 (Pubitemid 9242325)
42. Jeong S. H., Koo S. J., Choi J. H., Park J. H., Ha J., Park H. J., Lee K. T., Intermedeol isolated from the leaves of Ligularia fischeri var. spiciformis induces the differentiation of human acute promyeocytic leukemia HL-60 cells Planta Medica 2002 68 10 881 885 (Pubitemid 35239276)
43. Hunt R. C., Marshall L. M., Membrane protein redistribution during differentiation of cultured human erythroleukemic cells Molecular and Cellular Biology 1981 1 12 1150 1162 (Pubitemid 12178360)
44. Fang E. F., Ng T. B., Bitter gourd (Momordica charantia) is a cornucopia of health: a review of its credited antidiabetic, Anti-HIV, and antitumor properties Current Molecular Medicine 2011 11 5 417 436
45. Fang E. F., Zhang C. Z. Y., Ng T. B., Wong J. H., Pan W. L., Ye X. J., Chan Y. S., Fong W. P., Momordica charantia lectin, a type II ribosome inactivating protein, exhibits antitumor activity toward human nasopharyngeal carcinoma cells in vitro and in vivo Cancer Prevention Research 2012 5 1 109 121
46. Xue Y.-J., Han X.-H., Chen D., Huang H., Li X.-Q., Shao S.-H., Effects of recombinant MAP30 on cell proliferation and apoptosis of human esophageal carcinoma EC-1.71 cells African Journal of Pharmacy and Pharmacology 2011 5 24 2680 2688
47. Koeffler H. P., Induction of differentiation of human acute myelogenous leukemia cells: therapeutic implications Blood 1983 62 4 709 721 (Pubitemid 13008656)
48. Yazdanparast R., Mahdavi M., Moosavi M. A., Induction of differentiation and apoptosis in three human leukemia cell lines by a new compound from Dendrostellera lessertii Acta Biochimica et Biophysica Sinica 2006 38 7 477 483 (Pubitemid 44091739)
49. Bakare R. I., Magbagbeola O. A., Akinwande A. I., Okunowo O. W., Nutritional and chemical evaluation of Momordica charantia Journal of Medicinal Plant Research 2010 4 21 2189 2193
50. Henriksson M., Luscher B., Proteins of the myc network: essential regulators of cell growth and differentiation Advances in Cancer Research 1996 68 110 182 (Pubitemid 26099814)
51. Studzinski G. P., Brelvi Z. S., Feldman S. C., Watt R. A., Participation of c-myc protein in DNA synthesis of human cells Science 1986 234 4775 467 470 (Pubitemid 17181428)